Académique Documents
Professionnel Documents
Culture Documents
Mohamed Amr 32297 Sherif Mohamed Hussein 32259 Ehab Ahmed Mohamed 29978
TB Treatment
The response of TB to chemotherapy is slow and treatment must be administered for months to years. Usually, a drug-combination regimen is required ;otherwise microbial resistance develops rapidly.
Multidrug-resistant TB (MDR)
Multidrug-resistant TB is on the rise. MDR TB means that some TB bacteria have developed resistance, so that traditional antibiotics, like INH, no longer kill the bacteria. This is due to people not taking their medication properly; new strains of the bacteria evolve.
Anti-tuberculosis
Anti-tuberculosis drugs can be divided into two major categories: base on their efficacies and toxicities
First-line drugs: Isoniazid (INH), rifampin, pyrazinamide, ethambutol. Second-line drugs: streptomycin, paraaminosalicylic acid, kanamycin, amikacin, capreomycin, fluoroquinolone, ethionamide.
Isoniazid
It is bactericidal and bacteriostatic. Given orally on empty stomach. Adverse effects: Allergic reaction, hepatotoxicity and Peripheral neuritis due to pyridoxine deficiency.
Rifampin
of synthesis of mRNA.
It is bactericidal. Rifampin is absorbed orally. Adverse effects: Induction of P450 hepatic microsomal enzyme and flu-like syndrome.
Pyrazinamide
It is bactericidal and used in combination with INH and RFP. It is Quickly absorbed after orally administered. Adverse effects: Liver damage, urate retention may precipitate gouty attack.
Streptomycin
It is bactericidal and used in combination with INH and RFP. replaced by kanamycin or amkiacin in case of bacterial resistance.
Patient Education
Patient education is an essential component to prevent the spread of TB.
A surgical mask must be worn by a TB patient whenever they leave the isolation room.